EP1573332 - DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9A3 (PDE9A3) [Right-click to bookmark this link] | Status | The application has been refused Status updated on 24.06.2011 Database last updated on 06.07.2024 | Most recent event Tooltip | 24.06.2011 | Refusal of application | published on 27.07.2011 [2011/30] | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2006/44] |
Former [2005/37] | For all designated states Bayer HealthCare AG 51368 Leverkusen / DE | Inventor(s) | 01 /
GOLZ, Stefan Bückmannsmühle 46 45326 Essen / DE | 02 /
BRÜGGEMEIER, Ulf Leysiefen 20 42799 Leichlingen / DE | 03 /
SUMMER, Holger Katernberger Schulweg 3 42113 Wuppertal / DE | [2005/37] | Application number, filing date | 03780058.8 | 26.11.2003 | [2005/37] | WO2003EP13276 | Priority number, date | EP20020027530 | 09.12.2002 Original published format: EP 02027530 | [2005/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004053492 | Date: | 24.06.2004 | Language: | EN | [2004/26] | Type: | A1 Application with search report | No.: | EP1573332 | Date: | 14.09.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.06.2004 takes the place of the publication of the European patent application. | [2005/37] | Search report(s) | International search report - published on: | EP | 24.06.2004 | Classification | IPC: | G01N33/573, A61K38/00, A61K38/43 | [2005/37] | CPC: |
G01N33/573 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/37] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | DIAGNOSTIK UND THERAPIE FÜR KRANKHEITEN, DIE MIT HUMANE PHOSPHODIESTERASE 9A3 (PDE9A3) ASSOZIIERT SIND | [2005/37] | English: | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9A3 (PDE9A3) | [2005/37] | French: | DIAGNOSTIC ET TRAITEMENT DE MALADIES ASSOCIEES A LA PHOSPHODIESTERASE 9A3 (PDE9A3) HUMAINE | [2005/37] | Entry into regional phase | 11.07.2005 | National basic fee paid | 11.07.2005 | Designation fee(s) paid | 11.07.2005 | Examination fee paid | Examination procedure | 11.07.2005 | Examination requested [2005/37] | 25.01.2008 | Despatch of a communication from the examining division (Time limit: M06) | 23.07.2008 | Reply to a communication from the examining division | 10.02.2011 | Cancellation of oral proceeding that was planned for 22.03.2011 | 04.03.2011 | Despatch of communication that the application is refused, reason: substantive examination [2011/30] | 14.03.2011 | Application refused, date of legal effect [2011/30] | 22.03.2011 | Date of oral proceedings (cancelled) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.01.2008 | Fees paid | Renewal fee | 30.11.2005 | Renewal fee patent year 03 | 13.11.2006 | Renewal fee patent year 04 | 30.11.2007 | Renewal fee patent year 05 | 01.12.2008 | Renewal fee patent year 06 | 30.11.2009 | Renewal fee patent year 07 | 30.11.2010 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DX]US6350603 (LOUGHNEY KATE) [DX] 1-18,23 * examples 5-7 *; | [X] - GUIPPONI MICHEL ET AL, "Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: Alternative splicing of mRNA transcripts, genomic structure and sequence", HUMAN GENETICS, BERLIN, DE, (199810), vol. 103, no. 4, ISSN 0340-6717, pages 386 - 392, XP002234379 [X] 1-18,23 * the whole document * DOI: http://dx.doi.org/10.1007/s004390050838 | [ ] - EMBL, (19980720), Database accession no. AF067225 [ ] * column A * | [A] - LOUGHNEY K ET AL, "Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, (19990624), vol. 234, no. 1, ISSN 0378-1119, pages 109 - 117, XP004176895 [A] 1-18,23 * abstract * * page 112, column R, paragraph 3 - page 114, column L, paragraph 1; figures 1,2 * DOI: http://dx.doi.org/10.1016/S0378-1119(99)00171-7 | [A] - FRANCIS S H ET AL, "CYCLIC NUCLEOTIDE PHOSPHODIESTERASES: RELATING STRUCTURE AND FUNCTION", PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, ACADEMIC PRESS, US, (2000), vol. 65, ISSN 0079-6603, pages 1 - 52, XP000993322 [A] 1-18,23 * abstract * * page 39, paragraph 2 - paragraph L * DOI: http://dx.doi.org/10.1016/S0079-6603(00)65001-8 | [PX] - RENTERO CARLES ET AL, "Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, &, (20030214), vol. 301, no. 3, ISSN 0006-291X, pages 686 - 692, XP002275440 [PX] 1-18,23 * abstract * * page 686, paragraph 1 - page 687, paragraph 1; figure 4 * DOI: http://dx.doi.org/10.1016/S0006-291X(03)00021-4 | [PA] - WANG P ET AL, "Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5) - Differential tissue distribution and subcellular localization of PDE9A variants", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, (20030918), vol. 314, ISSN 0378-1119, pages 15 - 27, XP004460836 [PA] 1-18,23 * the whole document * DOI: http://dx.doi.org/10.1016/S0378-1119(03)00733-9 |